The US Food and Drug Administration (FDA) has approved a medical technology created by a University of Iowa faculty member to treat abnormal heart rhythms. Boston Scientific Corporation received FDA approval for the Farapulse™ Pulsed Field Ablation (PFA) System, a simple, cost-effective alternative to the standard-of-care thermal ablation treatment.